BiotechTube
Home/Ocumension Therapeutics/Dr. Li Ye
DL

Dr. Li Ye

CEO

Ocumension Therapeutics

Therapeutic Areas

Ophthalmology

Ocumension Therapeutics Pipeline

DrugIndicationPhase
OT-101Myopia ProgressionPhase 3
OT-301Dry Eye DiseasePhase 2
OT-401GlaucomaPhase 2

Leadership Team at Ocumension Therapeutics

DW
Dr. Wang Jian
CSO
View full Ocumension Therapeutics profile